Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Clinical Pharmacology and Therapeutics|February 16, 2007
A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapyA-K Hamberg, M-L Dahl, M Barban, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2010
Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extensionB Cosmi, C Legnani, A Tosetto, et al.
Thrombosis Research|May 31, 2011
Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)A Banzato, N Pozzi, R Frasson, et al.
Arthritis Care & Research|April 15, 2010
Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcomeA Ruffatti, A Calligaro, A Hoxha, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2002
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthaseE Iori, L Calò, D Valbusa, et al.
Archives of Internal Medicine|March 1, 2000
Oral anticoagulation treatment in the elderly: a nested, prospective, case-control studyG Palareti, J Hirsh, C Legnani, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2016
Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillationG Bertozzo, G Zoppellaro, S Granziera, et al.
Thrombosis Research|May 12, 2015
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profilesV Pengo, A Ruffatti, M Tonello, et al.
Journal of the American College of Cardiology|September 1, 1992
PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2S Dalla-Volta, A Palla, A Santolicandro, et al.
Internal and Emergency Medicine|November 30, 2007
Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinicsF Baudo, F de Cataldo, G Mostarda, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Clinical Pharmacology and Therapeutics|February 16, 2007
A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapyA-K Hamberg, M-L Dahl, M Barban, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2010
Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extensionB Cosmi, C Legnani, A Tosetto, et al.
Thrombosis Research|May 31, 2011
Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)A Banzato, N Pozzi, R Frasson, et al.
Arthritis Care & Research|April 15, 2010
Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcomeA Ruffatti, A Calligaro, A Hoxha, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2002
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthaseE Iori, L Calò, D Valbusa, et al.
Archives of Internal Medicine|March 1, 2000
Oral anticoagulation treatment in the elderly: a nested, prospective, case-control studyG Palareti, J Hirsh, C Legnani, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2016
Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillationG Bertozzo, G Zoppellaro, S Granziera, et al.
Thrombosis Research|May 12, 2015
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profilesV Pengo, A Ruffatti, M Tonello, et al.
Journal of the American College of Cardiology|September 1, 1992
PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2S Dalla-Volta, A Palla, A Santolicandro, et al.
Internal and Emergency Medicine|November 30, 2007
Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinicsF Baudo, F de Cataldo, G Mostarda, et al.
Pageof 17